Free tool
FAERS Monitor: Osmitrol 20% In Water In Plastic Container
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 013684 or its brand name (Osmitrol 20% In Water In Plastic Container, Mannitol). Reports on generic versions are filed under their own applications.
Reports
4,991
Serious
4,752
95% of reports
Hospitalization
2,191
Death reported
1,439
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- pain623
- renal failure592
- anxiety505
- injury495
- drug ineffective488
- stress478
- unevaluable event470
- fear430
- death428
- off label use400
- renal impairment394
- emotional distress386
- renal injury382
- nausea356
- vomiting338
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 116 |
| 2005 | 80 |
| 2006 | 90 |
| 2007 | 59 |
| 2008 | 87 |
| 2009 | 73 |
| 2010 | 105 |
| 2011 | 578 |
| 2012 | 255 |
| 2013 | 106 |
| 2014 | 181 |
| 2015 | 126 |
| 2016 | 228 |
| 2017 | 259 |
| 2018 | 218 |
| 2019 | 190 |
| 2020 | 226 |
| 2021 | 307 |
| 2022 | 379 |
| 2023 | 394 |
| 2024 | 395 |
| 2025 | 318 |
| 2026 | 220 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,049,168 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| fearSignal | 430 | 68.5 | 62.5 | 28,094 |
| renal injurySignal | 382 | 54.9 | 49.8 | 19,920 |
| injurySignal | 495 | 29.9 | 27.5 | 13,735 |
| stressSignal | 478 | 28.1 | 25.8 | 12,436 |
| unevaluable eventSignal | 470 | 26.3 | 24.2 | 11,401 |
| renal impairmentSignal | 394 | 19.9 | 18.1 | 7,030 |
| renal failureSignal | 592 | 18.9 | 17.5 | 10,017 |
| emotional distressSignal | 386 | 13.5 | 12.2 | 4,457 |
| anxietySignal | 505 | 7.5 | 6.9 | 2,867 |
| painSignal | 623 | 4.3 | 4.0 | 1,606 |
| vomitingSignal | 338 | 3.0 | 2.7 | 468 |
| deathSignal | 428 | 2.1 | 1.9 | 254 |
| off label use | 400 | 1.9 | 1.8 | 185 |
| nausea | 356 | 1.9 | 1.7 | 156 |
| drug ineffective | 488 | 1.6 | 1.4 | 104 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.